Delivering future health solutions.
Health & Life Sciences
#1 Biomanufacturing cluster in Europe
1st Life Sciences University Technical College in UK
#1 Research institution in the world for Tropical Medicine
One of largest concentrations of Cat 3 laboratories in the UK
There is no better validation of Liverpool City Region’s medical credentials than the global players that choose to locate and reinvest here. From stem cell and gene therapy treatments and nutraceuticals research and development, to large scale manufacturing and the production of pharmaceuticals, vaccines and biologics.
Liverpool City region is home to companies delivering world-class solutions in life sciences from research and trials to medical manufacturing, including AstraZeneca; Allergan; Baxter Healthcare, Bristol Myers Squibb; Lilly; Nestlé Health Science; Seqirus and Unilever. Significant new investments in modern production facilities at these companies have created a vibrant, efficient and cost-competitive environment to produce new drugs and vaccines.
The emergence of sensor technologies, big data and robotics is changing the possibilities and processes in the life sciences sector. Liverpool City Region is leading the way with its LCR 4.0 programme, creating a new infrastructure that connects physical and digital assets to make the industrial internet a reality. The Hartree Centre at Sci-Tech Daresbury is shaping the future of digital UK pharmaceutical design, development and manufacturing through big data analytics expertise.
Latest Health & Life Sciences news
Biotech company’s share price trebles after major deal with pharma giant
The value of Liverpool City Region and Cheshire based drug company Redx Pharma trebled in early trading after it revealed a deal with AstraZeneca which could be worth nearly £300m plus royalty payments.
Unilever renew membership with Sensor City to drive innovation
Sensor City will provide Unilever with a bespoke package of technical and business support over the next two years, as part of a joint commitment to drive innovation within Liverpool City Region.
LSTM receives multi million grant to improve product development for Infectious Diseases Prevention
LSTM has received a grant of £3,3million of the European Regional Development Fund to improve the product development in the formulation of infectious diseases therapeutics.
Sci-Tech Daresbury unveils next phase of development
Sci-Tech Daresbury has announced the next phase of its growth, with the Project Violet development that will comprise 42,000 sq ft of grade A office and innovation space for science and tech businesses.
Liverpool City Region consortium awarded lion’s share of £416m R&D funding
A consortium led by the Liverpool School of Tropical Medicine has today (June 26) been awarded £114m in government and industry funding as part of a package aimed at cutting-edge R&D projects.
Fit-out begins at £35m Royal College of Physicians HQ, ‘The Spine’
Fit-out work has started on the new £35m Royal College of Physicians (RCP) northern headquarters in Liverpool’s Paddington Village, The Spine – one of the world’s healthiest buildings.
ARCIS BIOTECH MOVE INTO LIVERPOOL CITY REGION’S TECHSPACE ONE
Biotech research business Arcis Biotechnology has moved to bigger Liverpool city region premises following a period of sustained growth.